Wellness Focus Cayman Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Focus Cayman Islands.

Press releases published on May 12, 2026

3 minutes ago

Newsmatics Launches 'Journalists Wanted' Initiative to Amplify Credible Journalism and Expand Audience Reach

Indeterminate EIN Presswire

an hour ago

Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree

Indeterminate GlobeNewswire

an hour ago

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

Indeterminate GlobeNewswire

an hour ago

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 

Indeterminate GlobeNewswire

an hour ago

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress

Indeterminate GlobeNewswire

an hour ago

Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026

Indeterminate GlobeNewswire

an hour ago

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

an hour ago

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

an hour ago

Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting

Indeterminate GlobeNewswire

an hour ago

BlossomHill Therapeutics to Present Initial Clinical Dose Escalation Data from the Phase 1/1b Trial of BH-30236 in Patients with R/R AML or HR-MDS at EHA2026

Indeterminate GlobeNewswire

an hour ago

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Indeterminate GlobeNewswire

an hour ago

Ajax Therapeutics Announces Oral Presentation of Clinical Results from AJX-101, a Phase I study of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the European Hematology Society (EHA) 2026 Congress

Indeterminate GlobeNewswire

an hour ago

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

Indeterminate GlobeNewswire

an hour ago

Cellectis présentera des données cliniques sur lasmé-cel et éti-cel au congrès annuel de l’EHA 2026

Indeterminate GlobeNewswire

an hour ago

Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits

Indeterminate GlobeNewswire

2 hours ago

PayZen Report: Healthcare Financial Pressures Mount as 73% of Systems Elevate Patient Payment Balances to a Top Priority

Indeterminate GlobeNewswire

2 hours ago

Four Winners Selected in PerfectServe’s 2026 Nurses of Note Awards Program

Indeterminate GlobeNewswire

2 hours ago

Ontra Launches AI-Powered DDQ Solution to Accelerate Investor Diligence for Private Markets Firms

Indeterminate GlobeNewswire

2 hours ago

Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026

Indeterminate GlobeNewswire

2 hours ago

JenaValve Appoints Dave Haan as Vice President of Clinical Affairs

Indeterminate GlobeNewswire